Market Place
Sourcing Support
VarmX Announces Appointment of John Glasspool as CEO
12 Nov 2024 //
BUSINESSWIRE
VarmX to Attend LSX World Congress and Bio€quity Europe in Q2 2024
28 Mar 2024 //
BUSINESSWIRE
VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO
12 Oct 2023 //
BUSINESSWIRE
Dutch biotech raises €30M for upscaled manufacturing
25 May 2023 //
ENPTS
VarmX Raises €30 Million Series B2 Financing for IND Approval
25 May 2023 //
BUSINESSWIRE
VarmX Appoints Dr. Jeffrey Lawson, MD, PhD as Chief Scientific Officer
08 Mar 2023 //
BUSINESSWIRE
VarmX to present new data at the ISTH Congress
08 Jul 2022 //
PHARMATIMES
First Subjects Dosed in First-in-Human Trial for VarmX’s, VMX-C001
15 Dec 2021 //
BUSINESSWIRE
VarmX to Present New Data on Lead Compound, VMX-C001, at the ISTH 2021
19 Jul 2021 //
FIRSTWORDPHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.